Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

Mapping the immune landscape of haematological cancers may help to enhance therapies

Mapping the immune landscape of haematological cancers may help to enhance therapies

NICE recommends brentuximab vedotin, in combination with chemotherapy, as frontline treatment for a rare type of lymphoma

NICE recommends brentuximab vedotin, in combination with chemotherapy, as frontline treatment for a rare type of...

A new nanoconjugate blocks acute myeloid leukaemia tumour cells without harming healthy ones

A new nanoconjugate blocks acute myeloid leukaemia tumour cells without harming healthy ones

FDA approves oral combination of decitabine and cedazuridine for myelodysplastic syndromes

FDA approves oral combination of decitabine and cedazuridine for myelodysplastic syndromes

Identified the genetic landscape of myelodysplastic/myeloproliferative neoplasms

Identified the genetic landscape of myelodysplastic/myeloproliferative neoplasms

Loss of intestinal goblet cells causes fatal disease after stem cell transplantation

Loss of intestinal goblet cells causes fatal disease after stem cell transplantation

New signposts in DNA for cancer and disease risk uncovered

New signposts in DNA for cancer and disease risk uncovered

Engineered immune cells recognise, attack human and mouse solid-tumour cancer cells

Engineered immune cells recognise, attack human and mouse solid-tumour cancer cells

Decades old mystery in leukaemia treatment solved

Decades old mystery in leukaemia treatment solved

Blood cell mutations linked to leukemias are inevitable as we age

Blood cell mutations linked to leukemias are inevitable as we age

More from ecancer